ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,451Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 86

$1.14M Total Retail Price of All Prescriptions

Rank: 17 out of 86

333 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 8,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $288 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
CRESTOR 452 384 1 9
OMEPRAZOLE 320 254 2 8
ZOLPIDEM TARTRATE 304 244 3 11
NEXIUM 273 222 4 14
LEVOTHYROXINE SODIUM 240 211 5 16
AMLODIPINE BESYLATE 236 192 6 3
METFORMIN HCL 226 195 7 17
SIMVASTATIN 225 165 8 5
DIOVAN 197 148 9 40
METOPROLOL SUCCINATE 195 161 10 15
MELOXICAM 169 137 11 27
DIOVAN HCT 155 114 12 20
CARVEDILOL 154 146 13 52
ATORVASTATIN CALCIUM 152 135 14 12
ALENDRONATE SODIUM 143 129 15 29
AZITHROMYCIN 142 96 16 28
GABAPENTIN 129 99 17 25
CLOPIDOGREL 117 105 18 34
CLOBETASOL PROPIONATE 101 65 19 129
GLIMEPIRIDE 100 65 20 39
TAMSULOSIN HCL 94 94 21 45
PLAVIX 93 87 22 47
GLYBURIDE 90 90 R 23 90
FLUTICASONE PROPIONATE 89 76 24 51
JANUVIA 87 64 25 37
FUROSEMIDE 87 71 25 21
CLOTRIMAZOLE-BETAMETHASONE 86 67 27 42
METOPROLOL TARTRATE 82 64 28 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 61 28 67
LOSARTAN POTASSIUM 81 70 30 60
ENALAPRIL MALEATE 78 57 31 24
HYDROCHLOROTHIAZIDE 75 75 32 22
CLONIDINE HCL 75 75 32 55
PANTOPRAZOLE SODIUM 74 71 34 109
IBANDRONATE SODIUM 71 66 35 152
AMLODIPINE BESYLATE-BENAZEPRIL 70 65 36 64
TRUVADA 66 24 37 2
BENICAR 66 66 37 155
LIDODERM 66 49 37 75
AMMONIUM LACTATE 66 57 37 155
DETROL LA 65 65 41 159
PROAIR HFA 65 57 41 19
TRAMADOL HCL-ACETAMINOPHEN 64 58 43 92
WARFARIN SODIUM 62 53 44 38
EXFORGE 62 58 44 88
LISINOPRIL 61 56 46 31
DEXILANT 60 44 47 104
ENDOCET 60 35 S2 47 18
ISOSORBIDE MONONITRATE ER 57 40 49 118
RAMIPRIL 56 53 50 83
LANTUS SOLOSTAR 56 45 50 124
VOLTAREN 56 39 50 58
LOSARTAN-HYDROCHLOROTHIAZIDE 56 46 50 41
CELEBREX 56 56 50 61
BENICAR HCT 55 45 55 126
OXYCODONE-ACETAMINOPHEN 53 39 S2 56 66
LANSOPRAZOLE 53 37 56 124
ALBUTEROL SULFATE 51 47 58 181
JANUMET 51 46 58 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.